Deals

The latest pharma deals — mergers, acquisitions, licensing agreements, and partnerships shaping the business of drug development worldwide.

glue scissors art supplies

Biotech

Novartis sticks 2nd deal with Orionis, this one worth up to $1.4B

Novartis stuck a second deal with Orionis, this time handing $40 million to the molecular glue biotech to work on “challenging therapeutic targets.”

James Waldron Jun 10, 2026 8:21am

AlzeCure

Lilly licenses AlzeCure Alzheimer’s asset for $1B biobucks

Jun 9, 2026 10:16am

Concepts of medical examination and study of intestine microflora

Galmed buys Colospan in $4.5M deal as it eyes $6B GI dx market

Jun 9, 2026 8:01am

Miels

GSK inks $10.6B Nuvalent buyout to challenge Roche and Pfizer

Jun 9, 2026 4:41am

forest

Treeline sees path to public markets via reverse merger

Jun 8, 2026 10:37am

Firefly

J&J makes $1B bet on emerging DAC space by netting Firefly Bio

Jun 8, 2026 10:05am